3 Arm Open-label Randomized Multidose Study of Pharmacokinetics, Safety & Tolerability of Testosterone Enanthate Administered Subcutaneously Via an Auto-injector Device or Intramuscular Testosterone Enanthate in Hypogonadal Adult Males
Phase of Trial: Phase I/II
Latest Information Update: 23 Oct 2015
At a glance
- Drugs Testosterone enanthate (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Antares Pharma
- 28 Sep 2015 Results published in Sexual Medicine, according to Antares Pharma media release.
- 13 Mar 2014 Positive results have been announced in an Antares media release.
- 27 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History